|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross margin | |||
| Operating expenses: | |||
| Research and development | |||
| Selling, General and Administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense): | |||
| Interest expense | |||
| Interest and other income | |||
| Change in fair value of convertible promissory notes | |||
| Change in fair value of warrant liability | |||
| Total other income | |||
| Net loss | |||
| Basic and diluted net loss per share | |||
| Weighted-average shares used to compute basic and diluted net loss per share | |||
| Earning per share, Diluted | |||
| Earnings per share, Basic | |||
| Weighted Average Number of Shares Outstanding, Diluted | |||
| Weighted Average Number of Shares Outstanding, Basic |
Loading...
